Mandate

Vinge advises Oncorena

January 13, 2022

Vinge advises Oncorena Holding AB in connection with an investment of initially SEK 66 million from Linc, HealthCap and Fåhraeus Startup and Growth.

The investment will primarily fund Oncorena’s first clinical study, a phase I/II study with orellanine in patients with advanced kidney cancer. In the event that the initial part of the clinical study provides positive results, the investors intend to finance the second part of the study with an additional SEK 94 million.

 

The Vinge team includes Christian Lindhé, Martin Svanberg and Sofie Nordgren.

Related

Vinge advises Radonova Laboratories on the acquisition of the Norwegian company Skandinavisk Radoninvest

Radonova Laboratories, a subsidiary of the Lagercrantz Group, has acquired all the shares in the Norwegian company Skandinavisk Radoninvest. Both companies operate in the field of radon measurement.
August 14, 2026

Vinge has advised KLAR Partners in connection with its divestment of Swoosh Group to Serwent

Swoosh is a leading provider of inspection, maintenance, and services for underground infrastructure in Sweden, delivering sewer pipe inspection, cleaning, repair, and maintenance to municipalities, industrial operators, and property owners across 23 sites nationwide. Swoosh today employs approximately 450 people and generates revenues of nearly SEK 700 million.
August 13, 2026

Vinge has advised Montrose by Carnegie AB on its application for authorisation to conduct securities business

Vinge has successfully advised Montrose by Carnegie AB in connection with its application to the Swedish Financial Supervisory Authority for authorisation to conduct securities business. The authorisation was granted by the Swedish Financial Supervisory Authority on 2 July 2026.
August 12, 2026